Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United Kingdom
This study is recruiting in the Netherlands. It focuses on Schizophrenia.
In NetherlandsThis study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomThis study is recruiting in the United States and in Japan. It is testing SEP-363856 for schizophrenia.
Multiple locations, including BentonvilleThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United Kingdom
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including New York
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.
Multiple locations, including MontrealThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
In PittsburghThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In MinneapolisThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Germany.
In BerlinThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.